CollPlant Biotechnologies... (CLGN)
NASDAQ: CLGN
· Real-Time Price · USD
2.64
0.04 (1.54%)
At close: Sep 04, 2025, 3:59 PM
2.62
-0.57%
After-hours: Sep 04, 2025, 04:04 PM EDT
1.54% (1D)
| Bid | 2.1 |
| Market Cap | 30.49M |
| Revenue (ttm) | 2.4M |
| Net Income (ttm) | -13M |
| EPS (ttm) | -1.13 |
| PE Ratio (ttm) | -2.34 |
| Forward PE | -65.75 |
| Analyst | Buy |
| Ask | 3 |
| Volume | 5,400 |
| Avg. Volume (20D) | 69,354 |
| Open | 2.56 |
| Previous Close | 2.60 |
| Day's Range | 2.56 - 2.65 |
| 52-Week Range | 1.31 - 5.45 |
| Beta | 0.78 |
About CLGN
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol CLGN
Website n/a
Analyst Forecast
According to 0 analyst ratings, the average rating for CLGN stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock ForecastsNext Earnings Release
CollPlant Biotechnologies Ltd. is scheduled to release its earnings on
Nov 26, 2025,
before market opens.
Analysts project revenue of ... Unlock content with Pro Subscription
Analysts project revenue of ... Unlock content with Pro Subscription
2 weeks ago
-20.24%
CollPlant Biotechnologies shares are trading lower...
Unlock content with
Pro Subscription
1 month ago
+15.28%
CollPlant Biotechnologies shares are trading higher after the company announced it has appointed Bowman Badley as the new head of its North American commercial operations for collagen biomaterials.
5 months ago · seekingalpha.com
CollPlant Biotechnologies Ltd. (CLGN) Q4 2024 Earnings Call TranscriptCollPlant Biotechnologies Ltd. (NASDAQ:CLGN ) Q4 2024 Earnings Conference Call March 26, 2025 10:00 AM ET Company Participants Dory Kurowski - LifeSci Advisors Yehiel Tal - CEO Eran Rotem - Deputy CEO...